Efflux pump induction by quaternary ammonium compounds and fluoroquinolone resistance in bacteria

Future Microbiology

Volumn 11, Issue 1, 2016, Pages 81-92

  Buffet Bataillon, Sylvie ^a   Tattevin, Pierre ^b,c   Maillard, Jean Yves ^d   Bonnaure Mallet, Martine ^e,f   Jolivet Gougeon, Anne ^a,e  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Pontchaillou   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITÉ DE RENNES 1   (France)

^f RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

antibiotic resistance; efflux pump; fluoroquinolone; integron; multidrug resistance; QAC; quaternary ammonium compounds

Indexed keywords

AMINOGLYCOSIDE; BIOCIDE; CHLORAMPHENICOL; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ERYTHROMYCIN; LINCOSAMIDE; QUATERNARY AMMONIUM DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; CARRIER PROTEIN; DISINFECTANT AGENT;

ANTIBIOTIC RESISTANCE; BIOFILM; CHEMICAL STRUCTURE; CROSS RESISTANCE; DNA REPLICATION; EFFUSION; HORIZONTAL GENE TRANSFER; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; ACTIVE TRANSPORT; BACTERIUM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGICAL STRESS; TRANSCRIPTION INITIATION;

BACTERIA; BIOFILMS; BIOLOGICAL TRANSPORT, ACTIVE; DISINFECTANTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MEMBRANE TRANSPORT PROTEINS; QUATERNARY AMMONIUM COMPOUNDS; STRESS, PHYSIOLOGICAL; TRANSCRIPTIONAL ACTIVATION;

EID: 84952684984     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.131     Document Type: Review

References (99)

1. Gerba CP. Quaternary ammonium biocides: efficacy in application. Appl. Environ. Microbiol. 81(2), 464-469 (2015).
2. Merianos JJ. Quaternary ammonium antimicrobial compounds. In: Disinfection, Sterilization, and Preservation (4th Edition). Block SS (Ed.). Lipincott Williams & Wilkins, PA, USA, 225-255 (1991).
3. Walker EB. Quaternary ammonium compounds. In: Handbook of Topical Antimicrobials: Industrial Applications in Consumer Products and Pharmaceuticals. Paulson D (Ed.). Marcel Dekker, NY, USA, 99-116 (2003).
4. Pesticide Action Network Europe. Biocides. www.pan-europe.info/campaigns/biocides
5. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J. Appl. Microbiol. 99(4), 703-715 (2005).
6. Xue Y, Hieda Y, Kimura K, Takayama K, Fujihara J, Tsujino Y. Kinetic characteristics and toxic effects of benzalkonium chloride following intravascular and oral administration in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 811(1), 53-58 (2004).
7. Clara M, Scharf S, Scheffknecht C, Gans O. Occurrence of selected surfactants in untreated and treated sewage. Water Res. 41(19), 4339-4348 (2007).
8. Sutterlin H, Alexy R, Coker A, Kummerer K. Mixtures of quaternary ammonium compounds and anionic organic compounds in the aquatic environment: elimination and biodegradability in the closed bottle test monitored by LC-MS/MS. Chemosphere 72(3), 479-484 (2008).
9. Biocidal Product Regulation. http://eur-lex.europa.eu
10. SCENIHR 2009. http://ec.europa.eu
11. Maillard JY, Bloomfield S, Coelho JR et al. Does microbicide use in consumer products promote antimicrobial resistance? A critical review and recommendations for a cohesive approach to risk assessment. Microb. Drug. Resist. 19(5), 344-354 (2013).
12. Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1,8-naphthyridine derivatives. A new class of chemotherapeutic agents. J. Med. Pharm. Chem. 91, 1063-1065 (1962).
13. Ball P. Quinolone generations: natural history or natural selection? J. Antimicrob. Chemother. 46(Suppl. T1), 17-24 (2000).
14. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis. 32(Suppl. 1), S9-S15 (2001).
15. Pruss GJ, Franco RJ, Chevalier SG, Manes SH, Drlica K. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants. J. Bacteriol. 168(1), 276-282 (1986).
16. Drlica K. Bacterial topoisomerases and the control of DNA supercoiling. Trends Genet. 6(12), 433-437 (1990).
17. Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin. Infect. Dis. 30(2), 243-254 (2000).
18. Ruiz J, Pons MJ, Gomes C. Transferable mechanisms of quinolone resistance. Int. J. Antimicrob. Agents 40(3), 196-203 (2012).
19. Putman M, van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64(4), 672-693 (2000).
20. Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 4(3), 223-229 (2013).
21. Li XZ, Zhang L, Poole K. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45(4), 433-436 (2000).
22. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 39(3), 162-176 (2007).
23. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51(5), 1109-1117 (2003).
24. Laskaris P, Tolba S, Calvo-Bado L, Wellington EM. Coevolution of antibiotic production and counter-resistance in soil bacteria. Environ. Microbiol. 12(3), 783-796 (2010).
25. Tezel U, Pavlostathis SG. Quaternary ammonium disinfectants: microbial adaptation, degradation and ecology. Curr. Opin. Biotechnol. 33, 296-304 (2015).
26. Wellington EM, Boxall AB, Cross P et al. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect. Dis. 13(2), 155-165 (2013).
27. Collis CM, Hall RM. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob. Agents Chemother. 39(1), 155-162 (1995).
28. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33(8), 1288-1294 (2001).
29. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289(7), 885-888 (2003).
30. Europa. Effects of biocides on antibiotic resistance. http://ec.europa.eu
31. WHO. Critically important antimicrobials for human medicine (3rd revision). www.who.int
32. Pagedar A, Singh J, Batish VK. Efflux mediated adaptive and cross resistance to ciprofloxacin and benzalkonium chloride in Pseudomonas aeruginosa of dairy origin. J. Basic Microbiol. 51(3), 289-295 (2011).
33. Ricci V, Busby SJ, Piddock LJ. Regulation of RamA by RamR in Salmonella enterica serovar typhimurium: isolation of a RamR superrepressor. Antimicrob. Agents Chemother. 56(11), 6037-6040 (2012).
34. Ricci V, Blair JM, Piddock LJ. RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease. J. Antimicrob. Chemother. 69(3), 643-650 (2014).
35. Morita Y, Cao L, Gould VC, Avison MB, Poole K. nalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa. J. Bacteriol. 188(24), 8649-8654 (2006).
36. Olliver A, Valle M, Chaslus-Dancla E, Cloeckaert A. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar typhimurium. FEMS Microbiol. Lett. 238(1), 267-272 (2004).
37. Webber MA, Talukder A, Piddock LJ. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates. Antimicrob. Agents Chemother. 49(10), 4390-4392 (2005).
38. Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol. Microbiol. 70(2), 462-478 (2008).
39. Oethinger M, Podglajen I, Kern WV, Levy SB. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42(8), 2089-2094 (1998).
40. Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44(1), 10-13 (2000).
41. Ricci V, Peterson ML, Rotschafer JC, Wexler H, Piddock LJ. Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrob. Agents Chemother. 48(4), 1344-1346 (2004).
42. Ricci V, Tzakas P, Buckley A, Piddock LJ. Ciprofloxacin-resistant Salmonella enterica serovar typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob. Agents Chemother. 50(1), 38-42 (2006).
43. Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP. Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb. Drug. Resist. 16(2), 91-104 (2010).
44. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol. Res. 2(1), 48-62 (2003).
45. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19(2), 382-402 (2006).
46. Costa SS, Viveiros M, Amaral L, Couto I. Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol. J. 7, 59-71 (2013).
47. Kumar S, Mukherjee MM, Varela MF. Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Int. J. Bacteriol. 2013 (2013).
48. Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Front. Microbiol. 6, 377 (2015).
49. Wassenaar TM, Ussery D, Nielsen LN, Ingmer H. Review and phylogenetic analysis of qac genes that reduce susceptibility to quaternary ammonium compounds in Staphylococcus species. Eur. J. Microbiol. Immunol. (Bp) 5(1), 44-61 (2015).
50. Buffet-Bataillon S, Le Jeune A, Le Gall-David S, Bonnaure-Mallet M, Jolivet-Gougeon A. Molecular mechanisms of higher MICs of antibiotics and quaternary ammonium compounds for Escherichia coli isolated from bacteraemia. J. Antimicrob. Chemother. 67(12), 2837-2842 (2012).
51. Morita Y, Murata T, Mima T et al. Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. J. Antimicrob. Chemother. 51(4), 991-994 (2003).
52. He GX, Kuroda T, Mima T, Morita Y, Mizushima T, Tsuchiya T. An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J. Bacteriol. 186(1), 262-265 (2004).
53. Maseda H, Hashida Y, Konaka R, Shirai A, Kourai H. Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens. Antimicrob. Agents Chemother. 53(12), 5230-5235 (2009).
54. Rushton L, Sass A, Baldwin A, Dowson CG, Donoghue D, Mahenthiralingam E. Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria. Antimicrob. Agents Chemother. 57(7), 2972-2980 (2013).
55. Morita Y, Tomida J, Kawamura Y. Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol. 4, 422 (2014).
56. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJ. Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J. Antimicrob. Chemother. 70(8), 2241-2248 (2015).
57. Rakic-Martinez M, Drevets DA, Dutta V, Katic V, Kathariou S. Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds. Appl. Environ. Microbiol. 77(24), 8714-8721 (2011).
58. Zhang M, O'Donoghue MM, Ito T, Hiramatsu K, Boost MV. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong. J. Hosp. Infect. 78(2), 113-117 (2011).
59. Furi L, Ciusa ML, Knight D et al. Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 57(8), 3488-3497 (2013).
60. Drlica K. Mechanism of fluoroquinolone action. Curr. Opin. Microbiol. 2(5), 504-508 (1999).
61. Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X. Quinolones: action and resistance updated. Curr. Top. Med. Chem. 9(11), 981-998 (2009).
62. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistancedetermining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34(6), 1271-1272 (1990).
63. Yoshida H, Bogaki M, Nakamura M, Yamanaka LM, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35(8), 1647-1650 (1991).
64. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs, 58(Suppl. 2), 11-18 (1999).
65. Zgur-Bertok D. DNA damage repair and bacterial pathogens. PLoS Pathog. 9(11), e1003711 (2013).
66. Baharoglu Z, Mazel D. SOS, the formidable strategy of bacteria against aggressions. FEMS Microbiol. Rev. 38(6), 1126-1145 (2014).
67. Ceragioli M, Mols M, Moezelaar R, Ghelardi E, Senesi S, Abee T. Comparative transcriptomic and phenotypic analysis of the responses of Bacillus cereus to various disinfectant treatments. Appl. Environ. Microbiol. 76(10), 3352-3360 (2010).
68. Poole K. Bacterial stress responses as determinants of antimicrobial resistance. J. Antimicrob. Chemother. 67(9), 2069-2089 (2012).
69. Mc Cay PH, Ocampo-Sosa AA, Fleming GT. Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology 156(Pt 1), 30-38 (2010).
70. Pagedar A, Singh J, Batish VK. Adaptation to benzalkonium chloride and ciprofloxacin affects biofilm formation potential, efflux pump and haemolysin activity of Escherichia coli of dairy origin. J. Dairy Res. 79(4), 383-389 (2012).
71. Baugh S, Phillips CR, Ekanayaka AS, Piddock LJ, Webber MA. Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J. Antimicrob. Chemother. 69(3), 673-681 (2014).
72. Jolivet-Gougeon A, Bonnaure-Mallet M. Biofilms as a mechanism of bacterial resistance. Drug Discov. Today Technol. 11, 49-56 (2014).
73. Ebrahimi A, Hemati M, Shabanpour Z et al. Effects of benzalkonium chloride on planktonic growth and biofilm formation by animal bacterial pathogens. Jundishapur J. Microbiol. 8(2), e16058 (2015).
74. Ortiz S, Lopez V, Martinez-Suarez JV. The influence of subminimal inhibitory concentrations of benzalkonium chloride on biofilm formation by Listeria monocytogenes. Int. J. Food Microbiol. 189, 106-112 (2014).
75. Wood TK, Knabel SJ, Kwan BW. Bacterial persister cell formation and dormancy. Appl. Environ. Microbiol. 79(23), 7116-7121 (2013).
76. Lewis K. Persister cells. Ann. Rev. Microbiol. 64, 357-372 (2010).
77. Madsen JS, Burmolle M, Hansen LH, Sorensen SJ. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 65(2), 183-195 (2012).
78. Gillings MR, Holley MP, Stokes HW. Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms. FEMS Microbiol. Lett. 296(2), 282-288 (2009).
79. Baharoglu Z, Bikard D, Mazel D. Conjugative DNA transfer induces the bacterial SOS response and promotes antibiotic resistance development through integron activation. PLoS Genet. 6(10), e1001165 (2010).
80. Baharoglu Z, Krin E, Mazel D. Connecting environment and genome plasticity in the characterization of transformation-induced SOS regulation and carbon catabolite control of the Vibrio cholerae integron integrase. J. Bacteriol. 194(7), 1659-1667 (2012).
81. van der Veen S, Abee T. Dependence of continuous-flow biofilm formation by Listeria monocytogenes EGD-e on SOS response factor YneA. Appl. Environ. Microbiol. 76(6), 1992-1995 (2010).
82. Hocquet D, Llanes C, Thouverez M et al. Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. PLoS Pathog. 8(6), e1002778 (2012).
83. Gaze WH, Abdouslam N, Hawkey PM, Wellington EM. Incidence of class 1 integrons in a quaternary ammonium compound-polluted environment. Antimicrob. Agents Chemother. 49(5), 1802-1807 (2005).
84. Gaze WH, Zhang L, Abdouslam NA et al. Impacts of anthropogenic activity on the ecology of class 1 integrons and integronassociated genes in the environment. ISME J. 5(8), 1253-1261 (2011).
85. Guerin E, Cambray G, Sanchez-Alberola N et al. The SOS response controls integron recombination. Science 324(5930), 1034 (2009).
86. Gaze WH, Krone SM, Larsson DG et al. Influence of humans on evolution and mobilization of environmental antibiotic resistome. Emerg. Infect. Dis. 19(7) (2013).
87. Xiong X, Bromley EH, Oelschlaeger P, Woolfson DN, Spencer J. Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a gram-negative bacterium. Nucleic Acids Res. 39(9), 3917-3927 (2011).
88. Jacoby G, Cattoir V, Hooper D et al. qnr gene nomenclature. Antimicrob. Agents Chemother. 52(7), 2297-2299 (2008).
89. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6(10), 629-640 (2006).
90. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 351(9105), 797-799 (1998).
91. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: A multifaceted threat. Clin. Microbiol. Rev. 22(4), 664-689 (2009).
92. Paulsen IT, Littlejohn TG, Radstrom P et al. The 3' conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob. Agents Chemother. 37(4), 761-768 (1993).
93. Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-betalactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53(12), 5046-5054 (2009).
94. Buffet-Bataillon S, Branger B, Cormier M, Bonnaure-Mallet M, Jolivet-Gougeon A. Effect of higher minimum inhibitory concentrations of quaternary ammonium compounds in clinical E. Coli isolates on antibiotic susceptibilities and clinical outcomes. J. Hosp. Infect. 79(2), 141-146 (2011).
95. Zou L, Meng J, McDermott PF et al. Presence of disinfectant resistance genes in Escherichia coli isolated from retail meats in the USA. J. Antimicrob. Chemother., 69(10), 2644-2649 (2014).
96. Sidhu MS, Heir E, Leegaard T, Wiger K, Holck A. Frequency of disinfectant resistance genes and genetic linkage with beta-lactamase transposon Tn552 among clinical staphylococci. Antimicrob. Agents Chemother. 46(9), 2797-2803 (2002).
97. Hughes D. Selection and evolution of resistance to antimicrobial drugs. IUBMB Life 66(8), 521-529 (2014).
98. SCENIHR 2010. http://ec.europa.eu
99. Knapp L, Amezquita A, McClure P, Stewart S, Maillard JY. Development of a protocol for predicting bacterial resistance to microbicides. Appl. Environ. Microbiol. 81(8), 2652-2659 (2015).